Elan Pharma (India) Private Limited, a active private limited company, was established on 04 June 1997 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH1997PTC108497. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹0.94 M.
It upholds a compliant status. Employing 321 professional, Its leadership includes Dandu Vijay Prakash Raju (Managing Director), Vidyadhar Dadu Sawant (Whole-Time Director). Past directors included Prakash Gunaji Sawardekar, Joseph Peter Sequeira, Vidyadhar Dadu Sawant. It holds no open charges and ₹4.93 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 501-Raikar Chambers Govandi, Deonar,, Mumbai, Maharashtra, 400088.
U24230MH1997PTC108497
108497
04 June 1997
₹2.50 M
₹0.94 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Elan Pharma (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dandu Vijay Prakash Raju | Managing Director | 04 Jun 1997 | Current |
| Vidyadhar Dadu Sawant | Whole-Time Director | 07 Sep 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Feb 2009 | Past |
| Pramod Abcsdd | Whole-Time Director | 01 Nov 2015 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2013 | Past |
| Pramod Abcsdd | Director | 07 Jul 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Elan Pharma (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.68% increase. The company also saw a substantial improvement in profitability, with a 18.65% increase in profit. The company's net worth Soared by an impressive increase of 20.44%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Elan Pharma (India) had a promoter holding of 96.12% and a public holding of 3.88%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹49,338,124.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Mar 2006 | Canara Bank | ₹1.79 Cr | Satisfied |
| 04 Feb 2003 | Canara Bank | ₹0.38 M | Satisfied |
| 05 Sep 2001 | Canara Bank | ₹2.80 Cr | Satisfied |
| 05 Sep 2001 | Canara Bank | ₹1.50 M | Satisfied |
| 02 Nov 1999 | Canara Bank | ₹0.55 M | Satisfied |
Explore comprehensive loan charge details -
Elan Pharma (India) has a workforce of 321 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Elan Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elan Pharma (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Elan Pharma (India) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
The activity Elan Pharma (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
A charge registered on 05 Sep 2001 via Charge ID 90143556 with Canara Bank was fully satisfied on 18 Nov 2020. was recorded as a recent event.
The activity A charge registered on 28 Mar 2006 via Charge ID 10016391 with Canara Bank was fully satisfied on 30 May 2018. was completed.
Progress on A charge registered on 04 Feb 2003 via Charge ID 90144306 with Canara Bank was fully satisfied on 30 May 2018. was documented.
Progress on A charge registered on 05 Sep 2001 via Charge ID 90146216 with Canara Bank was fully satisfied on 30 May 2018. was documented.
The CIN of Elan Pharma (India) Private Limited is U24230MH1997PTC108497.
Elan Pharma (India) Private Limited is headquartered at 501-Raikar Chambers Govandi, Deonar,, Mumbai, Maharashtra, 400088.
Elan Pharma (India) Private Limited was incorporated on 04 June 1997.
The current directors of Elan Pharma (India) Private Limited are
The primary industry of Elan Pharma (India) Private Limited is Manufacturing.
Elan Pharma (India) Private Limited is unlisted.
The authorized capital of Elan Pharma (India) Private Limited is ₹2.50 M, and the paid-up capital is ₹0.94 M.
The compliance status of Elan Pharma (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX